STO Equity Snapshot
SOBI Weekly Equity Report
Swedish Orphan Biovitrum AB (publ)
What the company does
Swedish Orphan Biovitrum AB (publ), a biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia. The company operates through three segments: Haematology, Immunology, and Specialty Care. It offers Alprolix for haemophilia B; ALTUVOCT for the treatment and prophylaxis of bleeding in patients with haemophilia A; Aspaveli/Empaveli for treating adult patients with paroxysmal nocturnal haemoglobinuria; Doptelet for the treatment of immune thrombocytopenia and thrombocytopenia; Elocta/Eloctate for the treatment and prophylaxis of bleeding in patients with haemophilia A; Gamifant for treating hemophagocytic lymphohistiocytosis; …
What the weekly tape is saying
SOBI closed the latest completed week at 439.2 SEK. The 4-week return is -0.4% and the 12-week return is 22.2%. Trend Signal is active, Market Dynamics is 1.19. Setup signature: Balanced read with a 72/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 382.9 SEK
- Vs Trend Line
- 14.7%
- Fair Value
- 297.4 SEK
- Vs Fair Value
- 47.7%
- 52W High
- 451.8 SEK
- 52W Low
- 261.2 SEK
- Drawdown
- -2.8%
- Range Position
- 93.4%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 35 weeks
- 52W Active Weeks
- 35
- 52W Active Breadth
- 67.3%
- Sector Scope
- SE Healthcare
- Sector Rank
- 81 of 158
- Sector Percentile
- 49.0%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
SE Healthcare
- Tracked Peers
- 100
- 4W Rank
- 46 of 100
- Avg 1W
- 2.8%
- Avg 4W
- 1.2%
- Trend Breadth
- 29.0%
- Positive MD
- 69.0%
SE Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 19
- 4W Rank
- 11 of 19
- Avg 1W
- 3.4%
- Avg 4W
- 5.3%
- Trend Breadth
- 36.8%
- Positive RS
- 26.3%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 1.19
- 4W MD Change
- 45.1%
- Relative Strength
- 17.49
- 4W RS Change
- -23.2%
- Expectation
- Undecided
- Probability
- 53.19%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 1.2M
- 13W Average
- 2.0M
- 52W Average
- 1.9M
- Vs 13W
- 0.6x
- Vs 52W
- 0.6x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 3.4%
- 52W Volatility
- 4.5%
- Upside Weeks
- 30
- Downside Weeks
- 22
- Downside Breadth
- 42.3%
- Avg Gain / Loss
- 3.7% / -2.8%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- STO
- Country
- SE
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- SEK
- Market Cap
- 153.1B
Opportunity signals
- Trend Signal is active with a 35-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Market Dynamics is positive on the latest completed week.
Risk signals
- No major top-level risk cluster is currently dominant.
Watch next
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 439.2 SEK | -1.7% | 382.9 SEK | 297.4 SEK | 1.19 | 17.49 | 1.2M | On |
| 5 Jun 2026 | 446.6 SEK | 1.0% | 379.6 SEK | 296.0 SEK | 1.05 | 19.85 | 2.3M | On |
| 29 May 2026 | 442.2 SEK | 0.2% | 375.6 SEK | 294.5 SEK | 1.03 | 18.25 | 3.8M | On |
| 22 May 2026 | 441.4 SEK | 0.1% | 371.8 SEK | 293.0 SEK | 0.93 | 18.18 | 1.5M | On |
| 15 May 2026 | 441.0 SEK | 1.3% | 367.7 SEK | 291.6 SEK | 0.82 | 22.77 | 1.6M | On |
| 8 May 2026 | 435.2 SEK | 1.7% | 363.4 SEK | 290.2 SEK | 0.84 | 20.16 | 2.7M | On |
| 1 May 2026 | 427.8 SEK | 6.9% | 358.9 SEK | 288.8 SEK | 0.64 | 19.00 | 2.4M | On |
| 24 Apr 2026 | 400.2 SEK | -4.9% | 355.1 SEK | 287.7 SEK | 0.53 | 10.19 | 1.4M | On |
| 17 Apr 2026 | 421.0 SEK | 3.6% | 350.8 SEK | 286.6 SEK | 0.56 | 13.24 | 1.7M | On |
| 10 Apr 2026 | 406.2 SEK | 1.3% | 346.2 SEK | 285.6 SEK | 0.34 | 12.18 | 1.5M | On |
| 3 Apr 2026 | 400.8 SEK | 3.9% | 341.6 SEK | 284.6 SEK | 0.24 | 16.43 | 1.8M | On |
| 27 Mar 2026 | 385.6 SEK | 7.3% | 337.5 SEK | 283.6 SEK | 0.20 | 16.28 | 1.9M | On |
| 20 Mar 2026 | 359.4 SEK | -3.6% | 334.2 SEK | 282.6 SEK | 0.41 | 8.71 | 2.0M | On |
| 13 Mar 2026 | 372.8 SEK | -1.0% | 331.9 SEK | 281.8 SEK | 0.86 | 7.28 | 1.6M | On |